Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.
The data in our infographic is based on a survey conducted in June 2020 with n=305 Canadian Physicians.
While COVID-19 has caused a reduction in workload, 45% of physicians anticipate becoming busier in the coming weeks/months. Despite being financially impacted by COVID-19, physicians agree with how their provincial government has managed the crisis. In our survey, 74% of physicians reported personal financial impact due to COVID-19 and 86% stated being in agreement with provincial government management of the situation.
As a result of COVID-19, physicians have become much more likely to meet with patients remotely and envision continuing to do so even after COVID-19 in under control. Similarly, physicians expect pharma rep interactions to keep more of a remote component even after COVID-19 in under control.
Past Quick Polls
Strong online advertising and messaging are key to maximizing impact of any marketing campaign. With recent restrictions on in-person interactions, online advertising and messaging play an even greater role in reaching physicians. Our findings from a survey of n=227 Canadian physicians show that 82% of Canadian physicians have increased their use of online platforms as a result of COVID-19, 48% significantly so.
Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always end up prescribing these new medications as much as they initially plan or as early as they would like. There are many reasons that can explain this discrepancy.
In October 2018, the use of recreational cannabis was legalized across Canada. Looking back at the past year, physicians remain divided in their views towards this new legislation, though support skews towards younger GPs. This legislation has impacted the use of prescription treatments and patient visits in a number of key therapeutic areas, though not to the degree that was anticipated 12 months ago.
Past Quick Polls
Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always...